“I was ready to make out my will, so this came along just at the right time,” the 76-year-old patient said. 

The new study, based on “the largest cohort to date of Harmony TPV recipients," was published in JACC: Cardiovascular Interventions.

In addition to these 15 late-breaking clinical studies, TVT 2023 will feature live cases, hands-on training, poster presentations and much more.

The new investments were announced as the company continues developing its CLAAS device for sealing the LAA during LAAO procedures.

Catch up on key late-breaking research from Abbott, Edwards Lifesciences and Philips presented at the four-day meeting in Paris.